图片来源: JD.com product page
黄连上清片
Huanglian Shangqing Tablets
| 生产企业 | 葵花药业 (Kuihua Pharmaceutical) |
|---|---|
| 剂型 | Film-coated tablets |
| 类别 | [中成药] |
适应症 / Indications
Relieves upper respiratory symptoms including headache, toothache, oral ulcers, sore throat, and constipation associated with acute inflammation.
产品说明 / Description
A tablet formulation of the same formula as Huanglian Shangqing Wan. Contains coptis, rhubarb, and 15 other botanical ingredients. The tablet form may offer more consistent dosing than the pill form. No independent clinical trials have been published for this formulation.
成分 / Ingredients
Coptis rhizome, rhubarb, gardenia fruit, scutellaria root, chrysanthemum flower, forsythia fruit, vitex fruit, schizonepeta spike, peppermint, phellodendron bark, saposhnikovia root, inula flower, gypsum, platycodon root, dahurian angelica root, licorice, Sichuan lovage rhizome.
◆ 临床证据 / Clinical Evidence
Same formula as Huanglian Shangqing Wan — no clinical trials for the tablet formulation specifically. The NMPA (China's FDA) approved it based on traditional use rather than modern clinical evidence. Berberine, the main active compound, has anti-inflammatory properties demonstrated in laboratory settings.
| 研究类型 | 文献来源 | 主要发现 |
|---|---|---|
| NMPA approval | NMPA database | Approved based on traditional use, not modern RCTs |
| Preclinical (berberine) | Multiple lab studies | Anti-inflammatory and antimicrobial effects in vitro |
